A phase I/ IIa study of tolerogenic vaccine for kidney transplantation

Trial Profile

A phase I/ IIa study of tolerogenic vaccine for kidney transplantation

Planning
Phase of Trial: Phase I/II

Latest Information Update: 19 May 2017

At a glance

  • Drugs Tolerogenic vaccine-Idogen (Primary)
  • Indications Haemophilia A
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 19 May 2017 New trial record
    • 11 May 2017 According to an Idogen media release, the company is being conducted with the intention of initiating a Phase I/IIa study within kidney transplantation in 2019.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top